Publications by authors named "Sarah Frys"

Claim this Profile
P
Pevonedistat, a NEDD8-activating enzyme inhibitor, is active in mantle cell lymphoma and enhances rituximab activity in vivo.
Natalie M Czuczman, Matthew J Barth, Juan Gu, Vishala Neppalli, Cory Mavis, Sarah E Frys

Blood· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Entinostat, a novel histone deacetylase inhibitor is active in B-cell lymphoma and enhances the anti-tumour activity of rituximab and chemotherapy agents.
Sarah Frys, Zachary Simons, Qiang Hu, Matthew J Barth, Juan J Gu

Br J Haematol· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis